Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories
-
Cantor Fitzgerald Reiterates Overweight Rating on FormFactor (FORM) on Long-Term Potential
-
Cantor Fitzgerald Reiterates Overweight Rating on Onto Innovation Inc. (ONTO) Ahead of Q2 Print
-
Cantor Fitzgerald: MKS Instruments (MKSI) 'Remains Our Top Pick Within the SMID Cap Space'
-
Cantor Fitzgerald Starts Critical Metals (CRML) at Spec. Buy
-
Q32 Bio launches $200M stock offering to fund clinical trials
-
Samos Energy raises $230M in NYSE IPO for energy acquisitions
-
Merlin Labs (MRLN) Reiterated at Overweight by Cantor Fitzgerald on Defense Programs
-
Rubrik (RBRK) Reiterated at Overweight by Cantor Fitzgerald Amid U.K. Expansion
-
GitLab (GTLB) Reiterated at Neutral by Cantor Fitzgerald on Consumption Trends, Strategy
-
Regeneron Pharma (REGN) Reiterated at Overweight by Cantor Fitzgerald
-
Annexon Biosciences (ANNX) Reiterate at Overweight by Cantor Fitzgerald on Vonaprument
-
Immunocore Holdings (IMCR) Reiterated at Overweight by Cantor Fitzgerald
-
Beta Technologies (BETA) Reiterate at Overweight by Cantor Fitzgerald as EIPPP Announced
-
Archer Aviation (ACHR) Reiterated at Overweight by Cantor Fitzgerald on EIPP Order
-
Rocket Lab USA (RKLB) Reiterated at Overweight by Cantor Fitzgerald After USSF Mission
-
Samos Energy prices IPO of 20M units at $10 each on NYSE
-
Opus Genetics (IRD) Reiterated at Overweight by Cantor Fitzgerald on Positive Update
-
Form 8-K Cantor Fitzgerald Income For: Jul 07
-
Willis Towers Watson (WTW) PT Raised to $344 at Cantor Fitzgerald on Better Q2 Setup
-
Ryan Specialty Group (RYAN) PT Raised to $34 at Cantor Fitzgerald as Shares Rally
-
RenaissanceRe Holdings (RNR) PT Raised to $354 at Cantor Fitzgerald on EPS Estimate Raise
-
Everest Group (EG) PT Raised to $390 at Cantor Fitzgerald on Likely 'Lighter Catastrophes'
-
Arch Capital (ACGL) PT Raised to $102 at Cantor Fitzgerald on Raised Estimates
-
W.R. Berkley (WRB) PT Raised to $74 at Cantor Fitzgerald on Stable Underlying Margins
-
Chubb Corporation (CB) PT Raised to $337 at Cantor Fitzgerald: 'Remains Well-Positioned'
-
Chubb Corporation (CB) PT Raised to $337 at Cantor Fitzgerald: 'Remains Well-Positioned'
-
Travelers (TRV) PT Raised to $360 at Cantor Fitzgerald on Evading Margin Deterioration
-
Cantor Fitzgerald Starts HCI Group (HCI) at Overweight
-
Cantor Fitzgerald Starts Merlin Labs (MRLN) at Overweight
-
Cantor Fitzgerald Starts Velo3D (VELO) at Overweight
-
Cantor Fitzgerald Upgrades American International Group (AIG) to Overweight
-
ON Semiconductor (ON) Reiterated at Neutral by Cantor Fitzgerald: Setup Positive
-
NXP Semiconductors NV (NXPI) Reiterated at Overweight by Cantor Fitzgerald: 'Best Value Play'
-
Microchip Technology (MCHP) Reiterated at Overweight by Cantor Fitzgerald on Likely Beat, Raise
-
Vera Therapeutics (VERA) Reiterated at Overweight by Cantor Fitzgerald on Trutakna Approval
-
DigitalOcean (DOCN) Reiterated at Overweight by Cantor Fitzgerald on Q2 Pre-Announcement
-
MasTec (MTZ) Reiterated at Overweight by Cantor Fitzgerald as Acquisition Agreement Announced
-
Alumis (ALMS) Reiterated at Overweight by Cantor Fitzgerald Ahead of Phase 2b SLE Readout
-
Analog Devices (ADI) Reiterated at Overweight by Cantor Fitzgerald on Likely Upside
-
Cantor Fitzgerald Assumes EyePoint Inc. (EYPT) at Overweight
-
Cantor Fitzgerald Starts Immuneering Corporation (IMRX) at Overweight
-
Form 8-K Cantor Fitzgerald Income For: Jul 07
-
Humana (HUM) PT Raised to $300 at Cantor Fitzgerald as Q/Q Enrollment Grows
-
HCA Healthcare Inc (HCA) PT Lowered to $528 at Cantor Fitzgerald Amid Difficult Setup
-
Elevance (ELV) PT Raised to $450 at Cantor Fitzgerald: Medicaid Cost Deterioration Unlikely
-
CVS Health (CVS) PT Raised to $110 at Cantor Fitzgerald Post Checks
-
Centene (CNC) PT Raised to $75 at Cantor Fitzgerald After Management Call, Checks
-
Capricor Therapeutics (CAPR) Reiterates Overweight Rating Ahead of Upcoming PDUFA
-
Vertex (VRTX) Reiterated at Overweight by Cantor Fitzgerald; Crinetics Acquisition Announced
-
Cantor Fitzgerald Downgrades Crinetics (CRNX) to Neutral

